FDA To Revise Warning Label On Bone Drugs

By John Metcalfe · October 13, 2010, 5:08 PM EDT

The U.S. Food and Drug Administration is revising the label on bisphosphonate-based osteoporosis drugs to warn consumers that they could raise the risk of a rare type of thigh-bone fracture....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

DUKE et al v. MERCK & CO., INC.

Case Number

Court

New Jersey

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

November 09, 2009

Recent Articles By John

November 05, 2010
Akzo, AstraZeneca Face 'Dead Peasant' Policy Suit
November 01, 2010
Pfizer Recalls 38,000 More Bottles Of Lipitor
October 29, 2010
Discovery Rule Applies To Stryker Pain Pumps: Judge
October 29, 2010
GSA Subcontractor Pleads Guilty To $1.9M Theft
October 28, 2010
AGA Medical Investor Sues Over $1.3B St. Jude Deal
October 21, 2010
COFC Says Army Health Care Center Contract Flawed
October 20, 2010
FDA Wants New Warnings On Prostate Cancer Drugs
October 12, 2010
Man's Pro Se Trademark Battle With 3M Nears End
October 06, 2010
Scientific Image FLSA Lawsuit Will Stay In Calif.
September 24, 2010
Abbott Hit With Class Action Over Bugs In Baby Formula